Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 13 | 2023 | 5860 | 1.350 |
Why?
|
Drug Eruptions | 6 | 2022 | 335 | 1.250 |
Why?
|
Melanoma | 9 | 2023 | 5702 | 1.240 |
Why?
|
Benzene | 1 | 2021 | 106 | 0.730 |
Why?
|
Sunscreening Agents | 1 | 2021 | 138 | 0.720 |
Why?
|
Veterans | 3 | 2022 | 2667 | 0.650 |
Why?
|
Bupivacaine | 1 | 2022 | 414 | 0.630 |
Why?
|
Skin Diseases | 3 | 2021 | 1084 | 0.600 |
Why?
|
Skin | 5 | 2022 | 4499 | 0.510 |
Why?
|
Prediabetic State | 1 | 2020 | 547 | 0.470 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1042 | 0.450 |
Why?
|
Metformin | 1 | 2020 | 907 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2022 | 4050 | 0.390 |
Why?
|
Dermatology | 2 | 2021 | 905 | 0.390 |
Why?
|
Disabled Persons | 1 | 2020 | 1209 | 0.360 |
Why?
|
Pemphigoid, Bullous | 2 | 2021 | 110 | 0.340 |
Why?
|
Neoplasms | 6 | 2022 | 22350 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3111 | 0.220 |
Why?
|
Immunotherapy | 4 | 2022 | 4747 | 0.200 |
Why?
|
Administration, Cutaneous | 2 | 2021 | 712 | 0.200 |
Why?
|
Lichenoid Eruptions | 1 | 2021 | 13 | 0.190 |
Why?
|
Dermatofibrosarcoma | 1 | 2021 | 49 | 0.190 |
Why?
|
Sezary Syndrome | 1 | 2021 | 80 | 0.170 |
Why?
|
Humans | 36 | 2023 | 766812 | 0.150 |
Why?
|
Physical Examination | 2 | 2022 | 1265 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1100 | 0.140 |
Why?
|
SEER Program | 1 | 2022 | 1444 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 12246 | 0.130 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3235 | 0.130 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 937 | 0.130 |
Why?
|
Placenta | 2 | 2022 | 1726 | 0.130 |
Why?
|
Anesthetics, Local | 1 | 2022 | 1005 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1737 | 0.110 |
Why?
|
Health Care Surveys | 1 | 2021 | 2425 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2039 | 0.110 |
Why?
|
Drug Hypersensitivity | 1 | 2022 | 903 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1163 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1768 | 0.100 |
Why?
|
Risk Factors | 4 | 2022 | 74889 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1594 | 0.090 |
Why?
|
United States | 4 | 2022 | 72945 | 0.090 |
Why?
|
Sarcoma | 1 | 2020 | 1802 | 0.080 |
Why?
|
Terminal Care | 1 | 2021 | 1769 | 0.080 |
Why?
|
Vitamin D | 1 | 2022 | 3270 | 0.080 |
Why?
|
Registries | 2 | 2022 | 8352 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4215 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2045 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2021 | 3079 | 0.070 |
Why?
|
Cohort Studies | 4 | 2022 | 41706 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5098 | 0.070 |
Why?
|
Retrospective Studies | 11 | 2021 | 81657 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3837 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26309 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3789 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3411 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5454 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39312 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10384 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5367 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7430 | 0.050 |
Why?
|
Adhesives | 1 | 2023 | 66 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3610 | 0.050 |
Why?
|
Private Practice | 1 | 2023 | 154 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5753 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24299 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5922 | 0.050 |
Why?
|
Antipruritics | 1 | 2020 | 31 | 0.040 |
Why?
|
Vitiligo | 1 | 2020 | 97 | 0.040 |
Why?
|
Electrons | 1 | 2021 | 264 | 0.040 |
Why?
|
Female | 10 | 2022 | 396532 | 0.040 |
Why?
|
Mohs Surgery | 1 | 2021 | 217 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54872 | 0.040 |
Why?
|
Pruritus | 1 | 2020 | 378 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2022 | 59548 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 576 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11218 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 29959 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 474 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9101 | 0.030 |
Why?
|
Male | 6 | 2022 | 364154 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1902 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1211 | 0.030 |
Why?
|
Adult | 3 | 2021 | 223305 | 0.020 |
Why?
|
Child | 4 | 2020 | 80670 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1884 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26387 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 30236 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36459 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3885 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3618 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42577 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9244 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5513 | 0.010 |
Why?
|
Aged | 3 | 2021 | 171344 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59939 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16722 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9407 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15912 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 223267 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8734 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88902 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40149 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16044 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30214 | 0.010 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_